Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company") is proud to announce its inclusion in the 2025 TSX Venture 50™, a prestigious annual ranking of the ...

Advancements in biologics, personalized medicine, and rising global prevalence drive the psoriasis treatment market's exponential growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Psoriasis Treatment ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Kiniksa Pharmaceuticals (NasdaqGS:KNSA) with a Buy ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

If your eczema is severe enough to warrant the use of a biologic, then you’ll most likely need lifelong treatment. There’s no cure for eczema. Most people with eczema benefit from the ...

Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their ...

Learn the vital steps to take when someone experiences a severe asthma attack, from recognizing danger signs to administering ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.Fourth positive DSMB ...